CXCL16 and chronic obstructive pulmonary disease: As a consequence, the increased plasma levels of CXCL16 in long-term smokers with normal LF and GOLD 1 patients suggest that soluble CXCL16 might be a new peripheral biomarker of COPD development risk in pre-COPD subjects.